JENNIE DONG: Open Payments
NPI 1255888590 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 23 payments from 15 companies in 2025. Trend: 2023 $3,614 · 2024 $2,592 · 2025 $900
Food & beverage: $892Education: $8
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $205 |
| Corcept Therapeutics | 2 | $159 |
| Madrigal Pharmaceuticals | 1 | $122 |
| Tandem Diabetes Care, Inc. | 1 | $104 |
| Dexcom, Inc. | 3 | $51 |
| Verity Pharmaceuticals Inc. | 2 | $48 |
| Abbott Laboratories | 1 | $33 |
| Insulet Corporation | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Ascendis Pharma Endocrinology Inc | 1 | $24 |
Products named: Korlym, Ozempic, REZDIFFRA, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, Tlando, FREESTYLE LIBRE 3, Omnipod.
Industry payments across AZ — which companies pay providers there.
